SUBSCRIBE
SUBSCRIBE
News   Business

Amorfix Life Sciences Ltd. Announces Fiscal 2009 Second Quarter Results

November 7, 2008 | 
1 min read
TORONTO, Nov. 6 /CNW/ - Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced its operational and financial results for the three and six months ended September 30, 2008.
Earnings
MORE ON THIS TOPIC
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
3D illustration of hair root growing from skin cells, symbolizing strength, growth, and nourishment. Perfect for haircare, cosmetic advertising, medical research, and healthcare concepts.
Funding
Veradermics Gets $150M Series C To Advance Hair Regrowth Pill
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing three businesspeople hanging on the edge of a cliff
Layoffs
Q3 Layoffs Up 280% YOY With CSL, Merck, Novo’s Restructurings
October 16, 2025
 · 
4 min read
 · 
Angela Gabriel